Gentian USA Inc

Bjørnåsveien 5
Moss,  N-1596

Norway

With 20+ years of industry experience and our unique and proprietary technologies, Gentian is a leader in PETIA development. Current immunoassay portfolio: cystatin C (510(k)-cleared/CE marked), serum and plasma calprotectin (CE marked/US research use only), canine CRP and fecal calprotectin assays with more under development including cardiovascular.